Ardsley Advisory Partners’s Pfizer PFE Stock Holding History

Ardsley Advisory Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-17,918	Closed	-$582K	–	165
2017 Q1	$582K	Buy	17,918 +5,270	+42%	+$166K	0.09%	92
2016 Q4	$390K	Sell	12,648 -10,540	-45%	-$322K	0.06%	94
2016 Q3	$745K	Sell	23,188 -3,320	-13%	-$111K	0.12%	81
2016 Q2	$886K	Sell	26,508 -10,382	-28%	-$331K	0.15%	68
2016 Q1	$1.04M	Sell	36,890 -15,810	-30%	-$452K	0.16%	60
2015 Q4	$1.61M	Hold	52,700	–	–	0.21%	60
2015 Q3	$1.57M	Hold	52,700	–	–	0.38%	50
2015 Q2	$1.69M	Buy	52,700 +7,905	+18%	+$258K	0.21%	66
2015 Q1	$1.48M	Sell	44,795 -10,540	-19%	-$335K	0.21%	66
2014 Q4	$1.64M	Hold	55,335	–	–	0.26%	53
2014 Q3	$1.55M	Buy	55,335 +7,905	+17%	+$222K	0.2%	54
2014 Q2	$1.34M	Sell	47,430 -295,120	-86%	-$8.41M	0.17%	77
2014 Q1	$10.4M	Buy	342,550 +115,940	+51%	+$3.46M	1.56%	18
2013 Q4	$6.58M	Sell	226,610 -31,620	-12%	-$920K	0.88%	32
2013 Q3	$7.04M	Sell	258,230 -500,650	-66%	-$13.6M	1.44%	22
2013 Q2	$20.2M	Buy	+758,880	New	+$21M	4.43%	3

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ardsley Advisory Partners's PFE Position: Q2 2017 in Review

Ardsley Advisory Partners sold out of Pfizer (PFE) in Q2 2017, closing a stake of 17,918 shares — an estimated $582K sold.

Ardsley Advisory Partners first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $20.2M in Q2 2013. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Ardsley Advisory Partners reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Ardsley Advisory Partners sold 17,918 Pfizer shares in Q2 2017, an estimated $582K.
Ardsley Advisory Partners first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
Ardsley Advisory Partners's Pfizer position peaked at $20.2M in Q2 2013.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Ardsley Advisory Partners's 13F filing for Q2 2017, filed 14 Aug 2017.